How to Score With Women (as a Marketer) via Social Media

A conversation with Casey Quinlan, 'Mighty Mouth' at Mighty Casey Media LLC, Zoe Dunn, Principal, Hale Advisors, Richard Meyer, Principal Consultant, Online Strategic Solutions, Jerry Hall, Digital Media Executive, Advisor to Pearescope, about engaging and marketing to women online, especially via social media, which some new media marketers claim is 'all about women.'

PhRMA Masters the Art of “Proofiness!”

In a recent video titled 'What Gets PhRMA's Chairman Up Every Morning?', Chris Viehbacher, CEO of Sanofi, cited an impressive Potemkin number related to life expectancy and the pharma industry.

Pharma Marketing News Vol. 10, No. 8: 28 April 2011

Welcome to Volume 10, Issue #8 (28 APRIL 2011) of Pharma Marketing News.

Digitally-Feeble Pharma

Is Your Brand a Digital Genius or a Feeble-Minded Idiot? When it comes to digital IQ, some brands are geniuses and some are feeble-minded idiots, according to the 'L2 Digital IQ Index' for pharmaceutical brands, a first-of-its kind measurement of the digital competence of 51 pharma brands across eight therapeutic categories.

Pharma Turns Up Heat to Unchill Off-Label “Free Speech”

The drug industry brings legal heat to the issue of off-label drug promotion.

Good Promotion Practices Alliance

Plenty of attention being paid to pharmaceutical marketing fraud and abuse cases in blogs and in the general media. But there hasn't been much attention paid to good compliance solutions or best practices. That's the mission of the Good Promotion Practices Alliance (GPP), which is co-sponsored by Reprints Desk and Prolifiq Software.

GSK’s U.S. Sales Reps “Europeanized”: No Longer Rewarded for Ability to Push Prescriptions

An anonymous poster to CafePharma described what the

The Big C in the Big Apple

HepC.tv is featuring the video 'Man-on-the-Street: New Yorkers' Reactions to the Big Yellow C.' Is it effective? How do we know?

Orphan Drugs Now “Where the Money Is,” Says Willie Sutton’s Ghost

Why do pharma companies bother developing drugs for for a disorder affecting fewer than 200,000 people? Willie Sutton's ghost may have the answer.

Pharma Marketing News Vol. 10, No. 13: 23 August 2011

Welcome to Volume 10, Issue #13 (23 AUGUST 2011) of Pharma Marketing News.

STAY CONNECTED

29,540FollowersFollow
- Advertisement -